NCT01677468

Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma

Phase Study About Feeding Artery Obliteration by Chemoembolization on Survival of Patients With Unresectable Hepatocellular Carcinoma

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 250 (estimated)
• Sponsor: Hallym University Medical Center · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study was to evaluate whether survival of patients who underwent TACE with unresectable HCC can benefit from intermediate-levels of embolization.

Detailed description

Subjective angiographic chemoembolization endpoints (SACE) levels were developed to standardize the embolic endpoints of transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). It determined the antegrade arterial flow and residual tumor blush as follows: I, normal-normal; II, reduced-reduced; III, reduced-none; IV, none-none. SACE level II and III indicates intermediate-levels of embolization, whereas IV indicates overembolization. The aim of this study was to evaluate whether survival of patients who underwent TACE with unresectable HCC can benefit from intermediate-levels of embolization.

Conditions

• Hepatocellular Carcinoma
• Transarterial Chemoembolization

Interventions

Type	Name	Description
PROCEDURE	Intermediate embolization	TACE with substasis using gelfoam
PROCEDURE	Complete embolization	TACE with complete embolization using gelfoam

Timeline

• Start date: 2012-08-01
• Primary completion: 2015-07-01
• Completion: 2015-07-01
• First posted: 2012-09-03
• Last updated: 2012-09-03

Locations

3 sites across 1 country: South Korea